![John Priatel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 8 M $ al 31/05/2026
John Priatel is currently an Independent Director at ME Therapeutics Holdings, Inc., a position held since 2023.
Education history includes an undergraduate degree earned in 1989 and a doctorate earned in 1997, both from the University of British Columbia.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 16/07/2026 | 4.469.261 ( 14,87 % ) | 8 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ME THERAPEUTICS HOLDINGS INC. | Director/Miembro de la Junta | 09/03/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ME Therapeutics Holdings, Inc.
 ME Therapeutics Holdings, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical services | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
